Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells

被引:551
作者
Castriconi, R
Cantoni, C
Della Chiesa, M
Vitale, M
Marcenaro, E
Conte, R
Biassoni, R
Bottino, C
Moretta, L
Moretta, A
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[2] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[3] Ist Giannina Gaslini, I-16148 Genoa, Italy
[4] Univ Genoa, Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
关键词
D O I
10.1073/pnas.0730640100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The surface density of the triggering receptors responsible for the natural killer (NK)-mediated cytotoxicity is crucial for the ability of INK cells to kill susceptible target cells. In this study, we show that transforming growth factor beta1 (TGFbeta1) down-regulates the surface expression of NKp30 and in part of NKG2D but not that of other triggering receptors such as NKp46. The TGFbeta1-mediated inhibition of NKp30 surface expression reflects gene regulation at the transcriptional level. NKp30 has been shown to represent the major receptor involved in the NK-mediated killing of dendritic cells. Accordingly, the TGFbeta1-dependent down-regulation of NKp30 expression profoundly inhibited the NK-mediated killing of dendritic cells. On the contrary, killing of different NK-susceptible tumor cell lines was variably affected, reflecting the differential usage of NKp30 and/or NKG2D in the lysis of such tumors. Our present data suggest a possible mechanism by which TGFbeta1producing dendritic cells may acquire resistance to the NK-mediated attack.
引用
收藏
页码:4120 / 4125
页数:6
相关论文
共 39 条
  • [1] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
    Bauer, Stefan
    Groh, Veronika
    Wu, Jun
    Steinle, Alexander
    Phillips, Joseph H.
    Lanier, Lewis L.
    Spies, Thomas
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233
  • [2] BELLONE G, 1995, J IMMUNOL, V155, P1066
  • [3] Bergmann L, 1995, EXP HEMATOL, V23, P1574
  • [4] Berking C, 2001, CANCER RES, V61, P8306
  • [5] Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO
  • [6] 2-Y
  • [7] Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
    Campbell, JJ
    Qin, SX
    Unutmaz, D
    Soler, D
    Murphy, KE
    Hodge, MR
    Wu, LJ
    Butcher, EC
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (11) : 6477 - 6482
  • [8] Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO
  • [9] 2-F
  • [10] Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia
    Costello, RT
    Sivori, S
    Marcenaro, E
    Lafage-Pochitaloff, M
    Mozziconacci, MJ
    Reviron, D
    Gastaut, JA
    Pende, D
    Olive, D
    Moretta, A
    [J]. BLOOD, 2002, 99 (10) : 3661 - 3667